Learn about all myeloma happenings on the new Myeloma Crowd site: the first comprehensive site for myeloma patients and caregivers. Dr. Aaron Rapoport, MD University of Maryland Greenbaum Cancer Center Interview date: March 28, 2014 Dr. Aaron Rapoport shares the progress being made on T cell and vaccine immunotherapy. T cell therapy is a way to use a patient's own immune system cells to target and eliminate myeloma cells, either by waking up and empowering T cells through engineering (called CAR T cells) or using a vaccine to stimulate the T cells to do their job. He shares how transplant is being used to eliminate the myeloma cells and T cells are being used to build back up the immune system to prevent future infections, like pneumonia. Although T cells are being used traditionally in combination with transplant, he shares how this is being used even without transplant in a newly opened study at the University of Maryland and City of Hope clinics. He shares how he and others are carefully moving forward with T cell approaches in order to create targets that just hit the myeloma cells while sparing healthy cells. He describes how you can join a T cell study by knowing your HLA tissue typing, an easy test to obtain that is performed by major labs. This test tissue typing is typically used if a patient is trying to find a donor transplant match. The live mPatient Myeloma Radio podcast with Dr. Aaron Rapoport
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.